Clinical insights and basic science correlates in sarcoidosis

American Journal of the Medical Sciences

Volumn 321, Issue 1, 2001, Pages 99-107

  Mandel, Jess ^a,b   Weinberger, Steven E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; MYCOBACTERIOSIS; SARCOIDOSIS;

EID: 0035162031     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200101000-00014     Document Type: Conference Paper

References (101)

1. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association
2. Granulomatous infections: Etiology and classification
3. The bilateral hilar lymphoma syndrome. A study of the relation to tuberculosis and sarcoidosis in 212 cases
4. The incidence of pulmonary sarcoidosis among the participants in a trial of tuberculosis vaccines
5. Adenopathies mediastinales benignes dans les suites de la vaccination par le B.C.G.
6. Images ganglio-pulmonaires d'aspect sarcoidosique chez les vaccines au B.C.G.
7. Detection of antibodies in serum against M. tuberculosis using western blot technique. Comparison between sarcoidosis patients and healthy subjects
8. Serologic reactivity against Mycobacterium paratuberculosis antigens in patients with sarcoidosis
9. Immunology of sarcoidosis
10. Differential diagnosis and evaluation of the solitary pulmonary nodule
11. Sarcoidosis with special reference to diagnosis and prognosis
12. Further observations on sarcoidosis associated with M. tuberculosis infection
13. Mycobacteria and sarcoidosis
14. Demonstration of acid-fast rods in sarcoidosis
15. The ultrastructure of the pulmonary granuloma in sarcoidosis
16. On the isolation of infectious agents from granulomas from patients with satcoid
17. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis
18. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction
19. Identification of Mycobacterium avium complex in sarcoidosis
20. Presence of mycobacterial DNA in sarcoidosis
21. Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation
22. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction
23. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction
24. Search for Mycobacterium paratuberculosis DNA in tissue from patients with sarcoidosis by enzymatic gene amplification
25. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions
26. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis
27. Sarcoidosis and mycobacterial L forms
28. Mycobacteria and sarcoidosis
29. Immunolocalization of cell-wall-deficient forms of Mycobacterium tuberculosis complex in sarcoidosis and in sinus histiocytosis of lymph nodes draining carcinoma
30. Mycobacteriophages: Their role in tuberculosis and sarcoidosis
31. Growth of acid fast L forms from the blood of patients with sarcoidosis
32. Incidence of sarcoidosis in the Isle of Man
33. Epidemiology of sarcoidosis in the Isle of Man - 1: A case-controlled study
34. Epidemiology of sarcoidosis in the Isle of Man - 2: Evidence for space time clustering
35. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation
36. Transmission of sarcoidosis via cardiac transplantation
37. Recurrence of sarcoidosis in pulmonary allograft recipients
38. Etiology of sarcoidosis
39. Borrelia burgdorferi infection may be the cause of sarcoidosis
40. Pulmonary sarcoidosis: Could mycoplasma-like organisms be a cause?
41. Human herpesvirus 8 variants in sarcoid tissues
42. High frequency of IgM antibodies to coxsackie B virus in sarcoidosis patients and patients with asbestos-related lesions
43. Sarcoidosis and infections by human lymphotropic viruses
44. Search for a retroviral cause for sarcoidosis: No evidence from peripheral blood studies
45. Anti-Borrelia burgdorferi immunoglobulin seroprevalence in pulmonary sarcoidosis: A negative report
46. Determination of antibodies to Borrelia burgdorferi in sarcoidosis
47. Is sarcoidosis a borreliosis?
48. Detection of Borrelia burgdorferi DNA in granulomatous tissues from patients with sarcoidosis using polymerase chain reaction in situ technique
49. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factoralpha and interleukin-6 but not interleukin-1 beta
50. Epidemiology of sarcoidosis in the United States
51. Epidemiologic investigations of sarcoidosis
52. Epidemiology of sarcoidosis
53. Sarcoidosis among U.S. Navy enlisted men, 1965-1993
54. Investigation of a unique time-space cluster of sarcoidosis in firefighters
55. Concepts of epidemiology of sarcoidosis: Preliminary report of 1194 cases reviewed with special reference to geographic ecology
56. Chemical constituents of pine pollen and their possible relationship to sarcoidosis
57. An evaluation of the possible relationship of pine pollen to sarcoidosis
58. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization
59. Genetics of sarcoidosis
60. Familial associations in sarcoidosis
61. Familial analysis of 91 families
62. Familial occurrence of sarcoidosis
63. Heterogeneity of familial risk in sarcoidosis
64. "The sarcoidosis map": A joint survey of clinical and immunogenetic findings in two European countries
65. Serum angiotensin converting enzyme in sarcoidosis - Its value in present clinical practice
66. Deletion polymorphisrn in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis
67. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis
68. Serum antibody response in sarcoidosis
69. Bronchoalveolar lavage in interstitial lung disease
70. Preferential usage of the T-cell antigen receptor beta-chain constant region C beta 1 element by lung T-lymphocytes of patients with pulmonary sarcoidosis
71. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis
72. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis
73. T-cell receptor variable region gene usage by CD4+ and CDS+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients
74. Chemical inactivation of the Kveim reagent
75. Nongranulomatous interstitial pneumonitis in sarcoidosis
76. Th1/Th2 cell distribution in pulmonary sarcoidosis
77. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with the clinical parameters
78. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
79. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis
80. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis
81. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis
82. Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung
83. Sarcoidosis after interferon therapy for chronic active hepatitis C
84. Recurrence of s arcoidosis following interferon alpha therapy for chronic hepatitis C
85. Sarcoidosis following beta-interferon therapy for multiple myeloma
86. HL-A antigens of patients with sarcoidosis
87. HLA-A,B and DR antigens in North Carolina Blacks with sarcoidosis
88. HLA antigens in sarcoidosis
89. HLA-B8 in sarcoidosis
90. Association of HLA B8 with spontaneous resolution in sarcoidosis
91. HLA antigens associated with sarcoidosis
92. Molecular genetic studies of HLA class II alleles in sarcoidosis
93. Genetic aspects of sarcoidosis. Class II histocompatibility antigens and a family study
94. Sarcoidosis and major histocompatibility complex genes with special emphasis on BF F subtypes
95. HLA class II (DR, DQ, DP) in patients with sarcoidosis: Evidence of an increased frequency of DRw6
96. Role of HLA-DR antigens in Japanese patients with sarcoidosis